Understanding Recent Developments in Colistin Resistance: Mechanisms, Clinical Implications, and Future Perspectives

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Colistin is a critical last-resort antibiotic for multidrug-resistant Gram-negative infections.
• Emergence of colistin resistance, via chromosomal mutations and plasmid-mediated MCR genes, threatens its clinical utility.
• Resistance leads to increased treatment failures, mortality, and healthcare burdens.

Purpose of the Study:

• To review the mechanisms of colistin resistance.
• To highlight the global spread of MCR genes.
• To emphasize the need for improved diagnostics and control strategies.

Main Methods:

• Literature review of studies on colistin resistance mechanisms.
• Analysis of epidemiological data on MCR gene dissemination.
• Synthesis of current challenges and future directions in combating resistance.

Main Results:

• Key resistance mechanisms include modifications to the bacterial lipid A.
• Plasmid-mediated MCR genes are rapidly spreading globally.
• Colistin resistance significantly increases patient morbidity and mortality.

Conclusions:

• A multifaceted approach is required to preserve colistin's efficacy.
• Enhanced antimicrobial stewardship and infection control are essential.
• Continued research into alternative treatments and rapid diagnostics is crucial for public health.